Should the huge list of side effects included in every prescription drug ad be shortened? The FDA wants your opinion.
from Forbes Real Time //www.forbes.com/sites/arleneweintraub/2017/08/29/fdas-gottlieb-wants-to-rein-in-risk-info-in-drug-ads-but-will-he-succeed/
via IFTTT
No comments:
Post a Comment